PAX6 and Alzheimer disease: Finally, we conducted co-staining of IDH3β and PAX6 in AD brain sections and observed a significant reduction in IDH3β+ signals and a robust increase in PAX6+ signals in an AD patient’s brain compared to healthy controls (Fig. 4r, s), indicating a strong negative correlation between these two proteins in vivo.